Published in Transplantation on April 01, 1991
Liver function after irradiation based on computed tomographic portal vein perfusion imaging. Int J Radiat Oncol Biol Phys (2007) 1.08
Prediction of liver function by using magnetic resonance-based portal venous perfusion imaging. Int J Radiat Oncol Biol Phys (2012) 0.99
Accuracy of indocyanine green pulse spectrophotometry clearance test for liver function prediction in transplanted patients. World J Gastroenterol (2004) 0.92
Adaptive trial of personalized radiotherapy for intrahepatic cancer. Per Med (2010) 0.92
Development and validation of insulin-like growth factor-1 score to assess hepatic reserve in hepatocellular carcinoma. J Natl Cancer Inst (2014) 0.86
Predicting morbidity and mortality after hepatic resection in patients with hepatocellular carcinoma: the role of Model for End-Stage Liver Disease score. World J Surg (2009) 0.86
Estimating functional liver reserve following hepatic irradiation: adaptive normal tissue response models. Radiother Oncol (2014) 0.84
Intermittent pringle maneuver and hepatic function: perioperative monitoring by noninvasive ICG-clearance. World J Surg (2009) 0.81
Pre- and post-transplant assessment of liver function in paediatric liver transplantation. Eur J Pediatr (1992) 0.79
Systemic vascular resistance in cirrhosis: a predictor of severity? Hepat Med (2014) 0.78
Levobupivacaine plasma concentrations following major liver resection. J Anesth (2011) 0.78
Validation of an IGF-CTP scoring system for assessing hepatic reserve in Egyptian patients with hepatocellular carcinoma. Oncotarget (2015) 0.77
Urinary metabolite profiling offers potential for differentiation of liver-kidney yin deficiency and dampness-heat internal smoldering syndromes in posthepatitis B cirrhosis patients. Evid Based Complement Alternat Med (2015) 0.77
Validation of a Modified Child-Turcotte-Pugh Classification System Utilizing Insulin-Like Growth Factor-1 for Patients with Hepatocellular Carcinoma in an HBV Endemic Area. PLoS One (2017) 0.75
20-year anniversary of Children's Hospital of the Medical School Hannover and paediatric transplantation. Eur J Pediatr (1992) 0.75
Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinoma. German Cancer Aid 17-1A Study Group. Lancet (1994) 3.24
Occupational exposure assessment in case-control studies: opportunities for improvement. Occup Environ Med (2002) 3.21
Surgical treatment of hepatocellular carcinoma: experience with liver resection and transplantation in 198 patients. World J Surg (1991) 3.12
SDZ RAD, a new rapamycin derivative: pharmacological properties in vitro and in vivo. Transplantation (1997) 2.80
The role of liver transplantation in hepatobiliary malignancy. A retrospective analysis of 95 patients with particular regard to tumor stage and recurrence. Ann Surg (1989) 2.71
Wnt 5a signaling is critical for macrophage-induced invasion of breast cancer cell lines. Proc Natl Acad Sci U S A (2006) 2.60
Antiviral cytotoxic T cell response induced by in vivo priming with a free synthetic peptide. J Exp Med (1990) 2.58
Cystatin C--a new marker of glomerular filtration rate in children independent of age and height. Pediatrics (1998) 2.50
Mutations in the MDR3 gene cause progressive familial intrahepatic cholestasis. Proc Natl Acad Sci U S A (1998) 2.17
Resectional surgery of hilar cholangiocarcinoma: a multivariate analysis of prognostic factors. J Clin Oncol (1997) 2.16
Etiologic classification of severe hypospadias: implications for prognosis and management. J Pediatr (1997) 2.09
Anti-viral protection and prevention of lymphocytic choriomeningitis or of the local footpad swelling reaction in mice by immunization with vaccinia-recombinant virus expressing LCMV-WE nucleoprotein or glycoprotein. Eur J Immunol (1989) 2.05
Basiliximab monotherapy following B-cell lymphoma after pediatric liver transplantation and anti-CD20 therapy. Pediatr Transplant (2003) 2.03
The wide spectrum of multidrug resistance 3 deficiency: from neonatal cholestasis to cirrhosis of adulthood. Gastroenterology (2001) 1.99
Normalised intrinsic mortality risk in liver transplantation: European Liver Transplant Registry study. Lancet (2000) 1.99
Chronic poisoning by copper in tap water: II. Copper intoxications with predominantly systemic symptoms. Eur J Med Res (1999) 1.99
Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection: a report of the European Tacrolimus Multicenter Renal Study Group. Transplantation (1997) 1.90
Benign liver tumors: differential diagnosis and indications for surgery. World J Surg (1997) 1.83
Total hepatectomy and liver transplantation as two-stage procedure. Ann Surg (1993) 1.83
Coherent membrane supports for parallel microsynthesis and screening of bioactive peptides. Biopolymers (2000) 1.82
Monoclonal antibody therapy for resected Dukes' C colorectal cancer: seven-year outcome of a multicenter randomized trial. J Clin Oncol (1998) 1.77
Developmental aspects of human hepatic drug glucuronidation in young children and adults. Gut (2002) 1.74
Cystatin C serum concentrations underestimate glomerular filtration rate in renal transplant recipients. Clin Chem (1999) 1.73
Antidepressant effects of augmentative transcranial magnetic stimulation: randomised multicentre trial. Br J Psychiatry (2007) 1.63
Incidence of Pneumocystis carinii pneumonia after renal transplantation. Impact of immunosuppression. Transplantation (1996) 1.61
In situ splitting of the liver in the heart-beating cadaveric organ donor for transplantation in two recipients. Transplantation (1995) 1.61
Cystic enlargement of extrahepatic bile ducts. Surgery (1993) 1.53
Lymphadenectomy in gastric carcinoma. A prospective and prognostic study. Arch Surg (1992) 1.53
Timbre-specific enhancement of auditory cortical representations in musicians. Neuroreport (2001) 1.52
Radical resection and liver grafting as the two main components of surgical strategy in the treatment of proximal bile duct cancer. World J Surg (1988) 1.51
In situ splitting of cadaveric livers. The ultimate expansion of a limited donor pool. Ann Surg (1996) 1.50
Autosomal recessive polycystic kidney disease in 115 children: clinical presentation, course and influence of gender. Arbeitsgemeinschaft für Pädiatrische, Nephrologie. Acta Paediatr (1996) 1.49
The development of experimental autoimmune encephalomyelitis in the mouse requires alpha4-integrin but not alpha4beta7-integrin. J Clin Invest (1998) 1.49
Hepatoblastoma in a child with progressive familial intrahepatic cholestasis. Pediatr Transplant (2005) 1.48
Long versus standard prednisone therapy for initial treatment of idiopathic nephrotic syndrome in children. Arbeitsgemeinschaft für Pädiatrische Nephrologie. Eur J Pediatr (1993) 1.48
Relationship of alcohol intake and sex steroid concentrations in blood in pre- and post-menopausal women: the European Prospective Investigation into Cancer and Nutrition. Cancer Causes Control (2006) 1.47
Phase I dose-escalation trial of gemcitabine and cisplatin for advanced non-small-cell lung cancer: usefulness of mathematic modeling to determine maximum-tolerable dose. J Clin Oncol (1996) 1.47
Expression of hepatitis B virus X protein in HBV-infected human livers and hepatocellular carcinomas. Hepatology (1998) 1.46
Evidence suggesting hyperoxaluria as a cause of nephrocalcinosis in phosphate-treated hypophosphataemic rickets. Lancet (1990) 1.45
Experiences with liver transplantation in Hannover. Hepatology (1984) 1.45
ICAM-1, VCAM-1, and MAdCAM-1 are expressed on choroid plexus epithelium but not endothelium and mediate binding of lymphocytes in vitro. Am J Pathol (1996) 1.45
Endotoxaemia in active Crohn's disease. Treatment with whole gut irrigation and 5-aminosalicylic acid. Gut (1986) 1.44
Long-term weight change and breast cancer risk: the European prospective investigation into cancer and nutrition (EPIC). Br J Cancer (2005) 1.44
What constitutes long-term survival after surgery for hilar cholangiocarcinoma? Cancer (1997) 1.43
Plasma vs whole blood for therapeutic drug monitoring of patients receiving FK 506 for immunosuppression. Clin Chem (1994) 1.43
Endogenous renal transport of free amino acids in infancy and childhood. Pediatrics (1968) 1.42
[Prolonged intensive care stay after abdominal surgery interventions with special reference to quality of life, occupational rehabilitation and economics]. Chirurg (1997) 1.42
[What is the role of nutrition in ulcerative colitis? A contribution to the current status of diet therapy in treatment of inflammatory bowel diseases]. Langenbecks Arch Chir (1995) 1.41
First experience with basiliximab in pediatric liver graft recipients. Pediatr Transplant (2001) 1.40
Adenine nucleotide metabolism and its relation to organ viability in human liver transplantation. Transplantation (1988) 1.39
Development of liver size and perfusion after reduced-size liver transplantation in children. Pediatr Transplant (2001) 1.39
Familial clustering of infantile cirrhosis in Northern Germany: A clue to the etiology of idiopathic copper toxicosis. J Pediatr (1999) 1.39
E- and P-selectin are not involved in the recruitment of inflammatory cells across the blood-brain barrier in experimental autoimmune encephalomyelitis. Blood (1997) 1.39
Vitrified sperm banks: the new aseptic technique for human spermatozoa allows cryopreservation at -86 °C. Andrologia (2012) 1.39
Application of adjusted survival curves to renal transplant data. Methods Inf Med (1992) 1.39
Long-term outcome in 134 patients with galactosaemia. Eur J Pediatr (1993) 1.39
[Multivariate analysis of prognostic factors after resection of ductal pancreatic carcinomas]. Langenbecks Arch Chir (1995) 1.38
Care of central venous catheters for total parenteral nutrition. Nutr Clin Pract (1996) 1.38
Recurrence patterns of hepatocellular and fibrolamellar carcinoma after liver transplantation. J Clin Oncol (1999) 1.38
Counselling quality in community pharmacies: implementation of the pseudo customer methodology in Germany. J Clin Pharm Ther (2005) 1.34
Auxiliary partial orthotopic liver transplantation (APOLT) for fulminant hepatic failure: first successful case report. World J Surg (1991) 1.31
Signs of hyperacute rejection of liver grafts in rhesus monkeys after donor-specific presensitization. Transplant Proc (1987) 1.30
Role of natural benzoxazinones in the survival strategy of plants. Int Rev Cytol (2000) 1.27
X-linked inhibitor of apoptosis (XIAP) deficiency: the spectrum of presenting manifestations beyond hemophagocytic lymphohistiocytosis. Clin Immunol (2013) 1.26
Long-term results after surgery for acute mesenteric ischemia. Surgery (1997) 1.26
Patterns of donor-type microchimerism after heart transplantation. Lancet (1994) 1.25
Identification of high- and low-risk patients before liver transplantation: a prospective cohort study of nutritional and metabolic parameters in 150 patients. Hepatology (1997) 1.24
Evidence for cerebral involvement in nephropathic cystinosis. Neuropadiatrie (1979) 1.24
Liver transplantation. Transplant Proc (1987) 1.23
Transcriptional activities of mammalian genomes at sites of recombination with foreign DNA. J Virol (1987) 1.23
Lignocaine metabolite formation as a measure of pre-transplant liver function. Lancet (1989) 1.23
Results of portal thrombectomy and splanchnic thrombolysis for the surgical management of acute mesentericoportal thrombosis. Br J Surg (1997) 1.22
Long-term outcome of hepatitis C virus infection after liver transplantation. Hepatology (1997) 1.21
β-catenin-independent WNT signaling in basal-like breast cancer and brain metastasis. Carcinogenesis (2010) 1.20
On the mechanism of recombination between adenoviral and cellular DNAs: the structure of junction sites. Curr Top Microbiol Immunol (1984) 1.20
Clinical pharmacokinetics of alfentanil, fentanyl and sufentanil. An update. Clin Pharmacokinet (1996) 1.20
A new technique of hepatic vein reconstruction in partial liver transplantation. Transpl Int (1988) 1.19
Progressive familial intrahepatic cholestasis: partial biliary diversion normalizes serum lipids and improves growth in noncirrhotic patients. Am J Gastroenterol (2000) 1.19
Production of cytokines (TNF-alpha, IL-1-beta) and endothelial cell activation in human liver allograft rejection. Transplantation (1993) 1.19
Recent weight changes and weight cycling as predictors of subsequent two year weight change in a middle-aged cohort. Int J Obes Relat Metab Disord (2002) 1.19
Liver support by extracorporeal blood purification: a clinical observation. Liver Transpl (2000) 1.18
Results of hepatic resection and transplantation for fibrolamellar carcinoma. Surg Gynecol Obstet (1992) 1.17
Sequelae after modified Fontan operation: postoperative haemodynamic data and organ function. Heart (1997) 1.17
Reference values for cystatin C serum concentrations in children. Pediatr Nephrol (1998) 1.17
Long-term experience after ex situ liver surgery. Surgery (2000) 1.16
Analysis of sequential changes in major histocompatibility complex expression in human liver grafts after transplantation. Transplantation (1988) 1.16
Nutritional consequences of total gastrectomy: the relationship between mode of reconstruction, postprandial symptoms, and body composition. Surgery (1990) 1.16
Resection of synchronous liver metastases from colorectal cancer. World J Surg (1991) 1.15
Compartment-oriented microdissection of regional lymph nodes in medullary thyroid carcinoma. Surg Today (1994) 1.14
Energy expenditure in children with type I diabetes: evidence for increased thermogenesis. BMJ (1989) 1.13
Prognostic factors after resection of ampullary carcinoma: multivariate survival analysis in comparison with ductal cancer of the pancreatic head. Br J Surg (1995) 1.13
Which is the best surgery for Budd-Chiari syndrome: venous decompression or liver transplantation? A single-center experience with 50 patients. Hepatology (1995) 1.13
Total hepatectomy as temporary approach to acute hepatic or primary graft failure. Transplant Proc (1988) 1.13